Marta Vázquez Cedeira-rekin lankidetzan egindako argitalpenak (10)

2018

  1. VRK1 and AURKB form a complex that cross inhibit their kinase activity and the phosphorylation of histone H3 in the progression of mitosis

    Cellular and Molecular Life Sciences, Vol. 75, Núm. 14, pp. 2591-2611

2014

  1. Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis

    Oncogene, Vol. 33, Núm. 21, pp. 2807-2813

  2. VRK1 interacts with p53 forming a basal complex that is activated by UV-induced DNA damage

    FEBS Letters, Vol. 588, Núm. 5, pp. 692-700

  3. Vaccinia-related kinase 1 (VRK1) confers resistance to DNA-damaging agents in human breast cancer by affecting dna damage response

    Oncotarget, Vol. 5, Núm. 7, pp. 1770-1778

2013

  1. Human VRK2 modulates apoptosis by interaction with Bcl-xL and regulation of BAX gene expression

    Cell Death and Disease, Vol. 4, Núm. 2

  2. Sensitivity of the kinase activity of human vaccinia-related kinase proteins to toxic metals

    Journal of Biological Inorganic Chemistry, Vol. 18, Núm. 4, pp. 473-482

  3. VRK2 identifies a subgroup of primary high-grade astrocytomas with a better prognosis

    BMC Clinical Pathology, Vol. 13, Núm. 1

2012

  1. Human VRK2 (vaccinia-related kinase 2) modulates tumor cell invasion by hyperactivation of NFAT1 and expression of cyclooxygenase-2

    Journal of Biological Chemistry, Vol. 287, Núm. 51, pp. 42739-42750

2011

  1. Differential inhibitor sensitivity between human kinases VRK1 and VRK2

    PLoS ONE, Vol. 6, Núm. 8

  2. Substrate profiling of human vaccinia-related kinases identifies coilin, a Cajal body nuclear protein, as a phosphorylation target with neurological implications

    Journal of Proteomics, Vol. 75, Núm. 2, pp. 548-560